Searched for
GSK HEALTHCARE
Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...- Global Markets: European shares edge higher with banks in the lead; the Middle East in focusEuropean markets saw a rise on Tuesday. Banking stocks led the gains, with Italian lenders drawing attention. Tech stocks stabilized after ...
- Haleon to invest Rs 2,000 crore to set up first India plantHaleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fas...
- On their toes: Brands step up anti-counterfeit drive as fake products flood marketsCompanies are fighting a rising tide of fake goods. Brands from toothpaste to cigarettes are changing packaging and tightening checks. Coun...
- Global Markets | European markets dip as investors eye earnings, Iran conflict continues to weighEuropean shares dipped on Wednesday, as investors turned their focus to a packed day of corporate earnings, while a continuing U.S.-Iran im...
- GSK Pharma to expand into oncology, focus on adult vaccines in IndiaGlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and oncology in Indi...
- Unilever still eyes GSK-Pfizer unit after £50 bn bid rebuffedGSK said on Saturday that it had received three unsolicited offers from Unilever for GSK Consumer Healthcare, but they were all rejected as...
- GSK launches global oral care brand Polident in IndiaDental experts and chemists will play a critical role in establishing the category in India, GSK said in the statement. “The company will w...
- CCI approves GSK, Pfizer joint venture in consumer healthcareGSK had in December last year announced that it had reached an agreement with Pfizer to combine the two companies’ consumer healthcare busi...
- CCI approves GSK, Pfizer consumer healthcare JV formationAfter the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business.
- GSK-Pfizer combo likely to be booster dose for brands in IndiaGSK and Pfizer said on Wednesday they will merge their consumer healthcare businesses, which have combined sales of $12 billion, by creatin...
- GSK may put iconic Horlicks for sale to fund $13-billion Novartis dealGSK is initiating a strategic review of Horlicks and its other consumer healthcare nutrition products to support funding the Novartis deal.
- Kraft Heinz to recall Complan ad ‘disparaging’ HorlicksGSK Consumer Healthcare India had filed a plea against the advertisement in the Delhi High Court earlier this week.
- GSK Health names Navneet Saluja as India Sub-continent headSaluja's last assignment with GSK Consumer Healthcare was that of Area General Manager in the Middle East and Africa.
- GST has come with hiccups but its execution has been good: GSK Consumer CEO"There have been hiccups as one would expect with any major change. Consumption was hit a bit in the short term by note ban and GST, but ex...
- GSK names Emma Walmsley as CEO-designateWalmsley had joined GSK in 2010 from L'Oreal where, over the course of her 17-year career, she held marketing and management positions in t...
- Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...
- GSK Consumer Healthcare India appoints Prashant Pandey as Marketing DirectorPandey will replace Jayant Singh who takes over as VP & General Manager of GSK Consumer Healthcare Brazil, GSK Consumer Healthcare India (G...
- Buy GSK Consumer Healthcare Ltd with a target of Rs 5490: Sandeep Wagle"GSK Consumer Healthcare Ltd is a 'BUY' call with a target of Rs 5490 and a stop loss of Rs 5085."
- GlaxoSmithKline Consumer Healthcare Ltd India-Novartis deal won't affect business in IndiaGlaxoSmithKline Consumer Healthcare today said the global deal between GlaxoSmithKline Plc and Novartis won't affect its business in India.
Load More
